# Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation

> **NCT07099014** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 300 (estimated)

## Conditions studied

- Cardiogenic Shock, ECMO

## Interventions

- **DRUG:** Inahled Isoflurane
- **DRUG:** Propofol, midazolam

## Key facts

- **NCT ID:** NCT07099014
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2028-10-13
- **Final completion:** 2029-04-13
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07099014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07099014, "Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07099014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*